Flurazepam

This classification denotes a benzodiazepine with the molecular formula C21H23ClFN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IHP475989U, chemically known as 7-chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1h-1,4-benzodiazepin-2(3h)-one but generally known as flurazepam, which bears US NIH Compound Identifier 3393. European Medicines Agency schedules Flurazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07744MIG. The term FLURAZEPAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, No. 10 1969, List 9). World Health Organization schedules flurazepam in its Anatomical Therapeutic Chemical (ATC) Classification. FLURAZEPAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule flurazepam under HS 29339190 and SITC 51577. As of Q4 2014, FLURAZEPAM remains the US FDA Preferred Term for this commodity. Flurazepam bears US NLM identifiers UMLS ID C0016375 and NCI Concept Code C62030. SMILES: CLC1CC2C(N(CCN(CC)CC)C(=O)CN=C2C2C(F)CCCC2)CC1.